Back
ESC Professional Premium Access

Does the use of anticoagulation or antiplatelet therapy increase cerebrovascular events in patients with infective endocarditis - a systematic review and meta-analysis

Session: Managing infective endocarditis: guidelines and beyond
Topic: Pharmacotherapy
Speaker: Associate Professor M. Diab (Rotenburg An Der Fulda, DE)
Event: ESC Congress 2023

Congress Presentation

About the speaker

Associate Professor Mahmoud Diab

Heart Centre of Rotenburg An Der Fulda, Rotenburg An Der Fulda (Germany)
0 follower

4 more presentations in this session

Association of anticoagulation with outcomes in patients with infective endocarditis

Speaker: Doctor S. Sheng (Stony Brook, US)

Access
Abstract
Slides
Video
Thumbnail

Initiation of warfarin is associated with decreased mortality in patients with infective endocarditis: a population based cohort study

Speaker: Mr T. Lee (Hong Kong, HK)

Access
Abstract
Slides
Video
Thumbnail

Prevalence, profile, causes and prognostic factors of surgical rejection in patients with left-sided infective endocarditis

Speaker: Doctor M. De Miguel (Valladolid, ES)

Access
Abstract
Slides
Video
Thumbnail

One-year outcome of elderly patients with endocarditis: a retrospective observational study

Speaker: Doctor F. Marchini (Ferrara, IT)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Managing infective endocarditis: guidelines and beyond

Speakers: Associate Professor M. Diab, Doctor S. Sheng, Mr T. Lee, Doctor M. De Miguel, Doctor F. Marchini
Access
Video
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb